First Light Asset Management LLC Buys 316,509 Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD)

First Light Asset Management LLC raised its holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) by 5.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,915,434 shares of the company's stock after purchasing an additional 316,509 shares during the period. KORU Medical Systems accounts for about 2.2% of First Light Asset Management LLC's holdings, making the stock its 16th biggest position. First Light Asset Management LLC owned 12.90% of KORU Medical Systems worth $22,774,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. JPMorgan Chase & Co. grew its position in shares of KORU Medical Systems by 2,770.7% in the fourth quarter. JPMorgan Chase & Co. now owns 17,712 shares of the company's stock valued at $68,000 after purchasing an additional 17,095 shares in the last quarter. Virtu Financial LLC bought a new position in KORU Medical Systems in the 4th quarter worth about $73,000. Y Intercept Hong Kong Ltd purchased a new position in KORU Medical Systems during the 4th quarter valued at about $104,000. Raymond James Financial Inc. bought a new stake in shares of KORU Medical Systems during the fourth quarter valued at about $118,000. Finally, HighTower Advisors LLC lifted its holdings in shares of KORU Medical Systems by 13.0% in the fourth quarter. HighTower Advisors LLC now owns 43,400 shares of the company's stock worth $167,000 after buying an additional 5,000 shares in the last quarter. 58.60% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

KRMD has been the subject of several analyst reports. Craig Hallum raised their price target on shares of KORU Medical Systems from $5.00 to $6.00 and gave the company a "buy" rating in a report on Friday, January 17th. B. Riley raised KORU Medical Systems to a "strong-buy" rating in a report on Thursday, March 13th. Lake Street Capital boosted their price objective on KORU Medical Systems from $4.00 to $5.00 and gave the stock a "buy" rating in a report on Tuesday, January 14th. Finally, Piper Sandler reaffirmed a "neutral" rating and issued a $4.50 target price on shares of KORU Medical Systems in a research note on Friday, February 14th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $4.70.

KORU Medical Systems Price Performance

Shares of KORU Medical Systems stock traded up $0.10 during trading on Friday, hitting $2.85. 164,269 shares of the stock traded hands, compared to its average volume of 140,653. The stock has a market cap of $131.50 million, a price-to-earnings ratio of -11.40 and a beta of 0.87. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. KORU Medical Systems, Inc. has a 52 week low of $1.86 and a 52 week high of $5.05. The firm's fifty day moving average is $2.69 and its 200-day moving average is $3.37.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.